
Cardinal Health rose 34.1% from $207.52 to $278.32, ahead of the S&P 500's +10.2%. Its worst day was Dec 3 (−5.9%), and its low came May 11 at $182.50.
Nov 19, 2025 – Nov 18, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Cardinal Health shares fell 5.9%, while the S&P 500 rose 0.1%.
−5.9%, the year's worst day, on 5M shares, the year's heaviest volume · S&P 500 +0.1%
EPS of $2.63 beat the $2.37 estimate on $65.6B revenue (est. $64.9B); FY EPS guidance of $10.15–$10.35 against the $10.04 consensus.
Story events cover the past 12 months · Times ET
+9.8%, the year's best day · S&P 500 −1.2%
EPS of $3.17 beat the $2.80 estimate on $60.9B revenue (est. $62.3B); FY EPS guidance of $10.70–$10.80 against the $10.32 consensus.
−4.9% · S&P 500 +1.0%
Cardinal Health closed at its lowest level of the year, 12.1% below where the year started.
−0.6% · S&P 500 +0.2%
EPS of $2.91 beat the $2.42 estimate on $63.7B revenue (est. $65.2B); FY EPS guidance of $12.40–$12.60 against the $12.05 consensus.
+1.3% · S&P 500 −0.3%
EPS of $3.26 beat the $2.94 estimate on $67.5B revenue (est. $66.6B); FY EPS guidance of $12.80–$13.00 against the $12.56 consensus.
+2.2% · S&P 500 −4.4%
Where it ended: a close of $278.32 on Nov 18, 2026. Up next: Q2 2027 earnings on Feb 4, 2027 (EPS est. $3.12, revenue est. $68.4B).
As of the Nov 18, 2026 close
Replay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for CAH and SPY from Benzinga historical bars. Not investment advice.